225 related articles for article (PubMed ID: 17574288)
21. beta-Lapachone-induced apoptosis in human prostate cancer cells: involvement of NQO1/xip3.
Planchon SM; Pink JJ; Tagliarino C; Bornmann WG; Varnes ME; Boothman DA
Exp Cell Res; 2001 Jul; 267(1):95-106. PubMed ID: 11412042
[TBL] [Abstract][Full Text] [Related]
22. Graphene oxide stabilized by PLA-PEG copolymers for the controlled delivery of paclitaxel.
Angelopoulou A; Voulgari E; Diamanti EK; Gournis D; Avgoustakis K
Eur J Pharm Biopharm; 2015 Jun; 93():18-26. PubMed ID: 25817600
[TBL] [Abstract][Full Text] [Related]
23. Solubility enhancement and in vitro evaluation of PEG-b-PLA micelles as nanocarrier of semi-synthetic andrographolide analogue for cholangiocarcinoma chemotherapy.
Puntawee S; Theerasilp M; Reabroi S; Saeeng R; Piyachaturawat P; Chairoungdua A; Nasongkla N
Pharm Dev Technol; 2016; 21(4):437-44. PubMed ID: 25738423
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and characterization of amphiphilic lipopolymers for micellar drug delivery.
Li F; Danquah M; Mahato RI
Biomacromolecules; 2010 Oct; 11(10):2610-20. PubMed ID: 20804201
[TBL] [Abstract][Full Text] [Related]
25. NQO1-Mediated Tumor-Selective Lethality and Radiosensitization for Head and Neck Cancer.
Li LS; Reddy S; Lin ZH; Liu S; Park H; Chun SG; Bornmann WG; Thibodeaux J; Yan J; Chakrabarti G; Xie XJ; Sumer BD; Boothman DA; Yordy JS
Mol Cancer Ther; 2016 Jul; 15(7):1757-67. PubMed ID: 27196777
[TBL] [Abstract][Full Text] [Related]
26. Development of beta-lapachone prodrugs for therapy against human cancer cells with elevated NAD(P)H:quinone oxidoreductase 1 levels.
Reinicke KE; Bey EA; Bentle MS; Pink JJ; Ingalls ST; Hoppel CL; Misico RI; Arzac GM; Burton G; Bornmann WG; Sutton D; Gao J; Boothman DA
Clin Cancer Res; 2005 Apr; 11(8):3055-64. PubMed ID: 15837761
[TBL] [Abstract][Full Text] [Related]
27. Intratumoral delivery of beta-lapachone via polymer implants for prostate cancer therapy.
Dong Y; Chin SF; Blanco E; Bey EA; Kabbani W; Xie XJ; Bornmann WG; Boothman DA; Gao J
Clin Cancer Res; 2009 Jan; 15(1):131-9. PubMed ID: 19118040
[TBL] [Abstract][Full Text] [Related]
28. β-Lapachone Induces NAD(P)H:Quinone Oxidoreductase-1- and Oxidative Stress-Dependent Heat Shock Protein 90 Cleavage and Inhibits Tumor Growth and Angiogenesis.
Wu Y; Wang X; Chang S; Lu W; Liu M; Pang X
J Pharmacol Exp Ther; 2016 Jun; 357(3):466-75. PubMed ID: 27048660
[TBL] [Abstract][Full Text] [Related]
29. Organic solvent-free low temperature method of preparation for self assembled amphiphilic poly(ϵ-caprolactone)-poly(ethylene glycol) block copolymer based nanocarriers for protein delivery.
Payyappilly SS; Panja S; Mandal P; Dhara S; Chattopadhyay S
Colloids Surf B Biointerfaces; 2015 Nov; 135():510-517. PubMed ID: 26291587
[TBL] [Abstract][Full Text] [Related]
30. Folate-conjugated amphiphilic star-shaped block copolymers as targeted nanocarriers.
Zhu J; Zhou Z; Yang C; Kong D; Wan Y; Wang Z
J Biomed Mater Res A; 2011 Jun; 97(4):498-508. PubMed ID: 21509931
[TBL] [Abstract][Full Text] [Related]
31. NAMPT inhibition sensitizes pancreatic adenocarcinoma cells to tumor-selective, PAR-independent metabolic catastrophe and cell death induced by β-lapachone.
Moore Z; Chakrabarti G; Luo X; Ali A; Hu Z; Fattah FJ; Vemireddy R; DeBerardinis RJ; Brekken RA; Boothman DA
Cell Death Dis; 2015 Jan; 6(1):e1599. PubMed ID: 25590809
[TBL] [Abstract][Full Text] [Related]
32. Design and evaluation of micellar nanocarriers for 17-allyamino-17-demethoxygeldanamycin (17-AAG).
Chandran T; Katragadda U; Teng Q; Tan C
Int J Pharm; 2010 Jun; 392(1-2):170-7. PubMed ID: 20363305
[TBL] [Abstract][Full Text] [Related]
33. Cyclic RGD conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect.
Zhan C; Gu B; Xie C; Li J; Liu Y; Lu W
J Control Release; 2010 Apr; 143(1):136-42. PubMed ID: 20056123
[TBL] [Abstract][Full Text] [Related]
34. Systemic delivery and preclinical evaluation of Au nanoparticle containing beta-lapachone for radiosensitization.
Jeong SY; Park SJ; Yoon SM; Jung J; Woo HN; Yi SL; Song SY; Park HJ; Kim C; Lee JS; Lee JS; Choi EK
J Control Release; 2009 Nov; 139(3):239-45. PubMed ID: 19619590
[TBL] [Abstract][Full Text] [Related]
35. Following anticancer drug activity in cell lysates with DNA devices.
Kahanda D; Singh N; Boothman DA; Slinker JD
Biosens Bioelectron; 2018 Nov; 119():1-9. PubMed ID: 30098460
[TBL] [Abstract][Full Text] [Related]
36. Preparation and Characterizations of RSPP050-Loaded Polymeric Micelles Using Poly(ethylene glycol)-b-Poly(ε-caprolactone) and Poly(ethylene glycol)-b-Poly(D,L-lactide).
Eawsakul K; Chinavinijkul P; Saeeng R; Chairoungdua A; Tuchinda P; Nasongkla N
Chem Pharm Bull (Tokyo); 2017; 65(6):530-537. PubMed ID: 28566645
[TBL] [Abstract][Full Text] [Related]
37. Tailored Beta-Lapachone Nanomedicines for Cancer-Specific Therapy.
Li Y; Feng M; Guo T; Wang Z; Zhao Y
Adv Healthc Mater; 2023 Aug; 12(20):e2300349. PubMed ID: 36970948
[TBL] [Abstract][Full Text] [Related]
38. Synergistic effects of radiation and beta-lapachone in DU-145 human prostate cancer cells in vitro.
Suzuki M; Amano M; Choi J; Park HJ; Williams BW; Ono K; Song CW
Radiat Res; 2006 May; 165(5):525-31. PubMed ID: 16669706
[TBL] [Abstract][Full Text] [Related]
39. In-vitro cytotoxicity and combination effects of the docetaxel-conjugated and doxorubicin-conjugated poly(lactic acid)-poly(ethylene glycol)-folate-based polymeric micelles in human ovarian cancer cells.
Hami Z; Rezayat SM; Gilani K; Amini M; Ghazi-Khansari M
J Pharm Pharmacol; 2017 Feb; 69(2):151-160. PubMed ID: 28044342
[TBL] [Abstract][Full Text] [Related]
40. Biodegradable polymer-curcumin conjugate micelles enhance the loading and delivery of low-potency curcumin.
Yang R; Zhang S; Kong D; Gao X; Zhao Y; Wang Z
Pharm Res; 2012 Dec; 29(12):3512-25. PubMed ID: 22961588
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
